UOC
CORZ

UBS O'Connor’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

UBS O'Connor’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-399,195
Closed -$3.92M – 1020
2021
Q2 		$3.92M Buy
+399,195
New +$3.93M 0.04% 325

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

UBS O'Connor's CORZ Position: Q3 2021 in Review

UBS O'Connor sold out of Core Scientific, Inc. Common Stock (CORZ) in Q3 2021, closing a stake of 399,195 shares — an estimated $3.92M sold.

UBS O'Connor first reported a position in CORZ in Q2 2021 and held it in 1 quarter. The position peaked at $3.92M in Q2 2021. 83 funds tracked by Wall St. Rank hold CORZ as of Q3 2021.

  • UBS O'Connor reported no remaining Core Scientific, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • UBS O'Connor sold 399,195 Core Scientific, Inc. Common Stock shares in Q3 2021, an estimated $3.92M.
  • UBS O'Connor first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • UBS O'Connor's Core Scientific, Inc. Common Stock position peaked at $3.92M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.